Inventor · disambiguated record
Reid O'Brien Johnson
Also filed as: O'BRIEN-JOHNSON REID
1 granted patent·5 pending applications·0 citations·filing 2020–2024
13Inventor score
Technology areasG01N
Files withREGENERON PHARMA6
Top patents by PatentIndex Score
6 records- 0172US2025003982A1Heavy peptide approach to accurately measure unprocessed c-terminal lysineREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0261US12123879B2Heavy peptide approach to accurately measure unprocessed C-terminal lysineREGENERON PHARMA·Filed 2021·Granted Oct 22, 2024·0 cites·12 claims
- 0352US2023266335A1Maximizing hydrophobic peptide recovery using a mass spectrometry compatible surfactantREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0449US2022074950A1Method for detecting host cell proteins in therapeutic antibodies by combining trypsin digestion, chromatography gradients, and boxcar mass spectrometryREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 0547US2022326252A1Electron transfer dissociation and mass spectrometry for improved protein sequencing of monoclonal antibodiesREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0643US2021109107A1Methods for characterizing host-cell proteinsREGENERON PHARMA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Reid O'Brien Johnson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →